Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-Guided Dry Needling, Lidocaine, and Oxygen-Ozone for Myofascial Pain Syndrome
NCT07738783Completed
- Sponsor
- Derince Training and Research Hospital
- Start
- Jun 2025
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial of Lidocaine Hydrochloride Injection, without epinephrine and oxygen + ozone in myofascial pain syndrome (MPS) (3 arms), sponsored by Derince Training and Research Hospital. Primary endpoint: Visual Analog Scale at Week 12. Started Jun 2025; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrineoxygen + ozone
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT07738783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07738783.